These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6683278)

  • 1. A comparative evaluation on nonspecific immunoparameters and CEA as a tumor marker in urogenital cancer patients.
    Nakagami Y; Minowa T; Tozuka K; Hiraoka Y; Chin H; Matsumoto K
    Nihon Ika Daigaku Zasshi; 1983 Apr; 50(2):292-4. PubMed ID: 6683278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Negative aspects clinical evaluation of CEA in patients with urogenital carcinoma (author's transl)].
    Kato J; Tsugaya M; Otaguro K
    Nihon Hinyokika Gakkai Zasshi; 1979 Jul; 70(7):793-8. PubMed ID: 502104
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological evaluation in urologic tumors].
    Glait HM; Scorticati C; Feierstein JN; Bellora O; Koss A; Olivari JA
    Arch Esp Urol; 1981; 34(6):437-60. PubMed ID: 6177291
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic assessment of urogenital carcinoma].
    Chou YH; Huang CH; Chiang CP
    Taiwan Yi Xue Hui Za Zhi; 1983 Nov; 82(11):1163-9. PubMed ID: 6584541
    [No Abstract]   [Full Text] [Related]  

  • 5. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
    Hering H; Hering FJ; Weidner W
    Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen (CEA) in the plasma and urine of patients with urologic cancer.
    Thitipraserth A; Ablin R; Bush I; Guinan P
    Proc Inst Med Chic; 1973; 29(9):323. PubMed ID: 4737044
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters.
    Wanebo HJ; Rao B; Attiyeh F; Pinsky C; Middleman P; Stearns M
    Cancer; 1980 Mar; 45(5 Suppl):1254-63. PubMed ID: 7357518
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal.
    Coombers GB; Hall RR; Laurence JR; Neville AM
    Br J Cancer; 1975 Feb; 31(2):135-42. PubMed ID: 1164465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 13. [The epicutaneous DNCB test and CEA determination in neoplasms of the breast, digestive tract, lung and urogenital system].
    Bianucci P; Pastorino G; De Rossi O; Brondi P
    Minerva Med; 1979 Dec; 70(54):3701-4. PubMed ID: 574929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the immunologic competence in patients with urogenital cancers. I. Evaluation of nonspecific cellular immunity by delayed cutaneous hypersensitivity test and lymphocytes blastoid formation (author's transl)].
    Ono H
    Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):1064-77. PubMed ID: 7198700
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of carcinoembryonic antigen (CEA): comparison of two different assays.
    Orjasaeter H
    Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):265-75. PubMed ID: 726896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of a multi-modal schedule for the treatment of disseminated breast cancer.
    McIntosh IH; Bejrajati P; Goodfellow T; Palmer BV; Greening WP
    Dev Biol Stand; 1977 Apr 13-15; 38():471-6. PubMed ID: 344101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiology of genitourinary tumors.
    Lange PH; Hakala TR; Fraley EE
    Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
    [No Abstract]   [Full Text] [Related]  

  • 18. Report of the workshop on the carcinoembryonic antigen (cea): the present position and proposals for future investigation.
    Neville AM; Laurence DJ
    Int J Cancer; 1974 Jul; 14(1):1. PubMed ID: 4142460
    [No Abstract]   [Full Text] [Related]  

  • 19. [CEA determination in urogenital tract neoplasms].
    Hering H; Weidner W; Hering F
    Med Lab (Stuttg); 1976 Sep; 29(9):193-8. PubMed ID: 979885
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of serum ferritin level in urologic cancer (author's transl)].
    Kido A; Machida T; Miki M; Ohishi Y; Sasaki T; Sasaki T; Ueda M; Ueda M; Yanagisawa M; Yanagisawa M; Tashiro K; Tashiro K; Iio M; Iio M; Yamada H; Yamada H; Kuroda A; Kuroda A
    Nihon Hinyokika Gakkai Zasshi; 1980 Apr; 71(4):383-90. PubMed ID: 7401417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.